Women with a previous history of breast cancer and women known to carry BRCA1 and BRCA2 mutations have a different breast cancer risk profile than the general population.

the verdict

SUPPORTED

the evidence backs this

Recorded sources

5 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Is it true that women with a previous history of breast cancer and women known to carry BRCA1 and BRCA2 mutations have a different breast cancer risk profile than the general population?

Yes. Multiple studies substantiate that women with a previous history of breast cancer and those carrying BRCA1 or BRCA2 mutations exhibit distinct, elevated breast cancer risk profiles compared with the general population.

Verdict: SUPPORTED · 5 sources for, 0 against · Last checked 3 Oct 2026

The analysis

The retrieved literature consistently supports the claim that both BRCA mutation carriers and survivors with a prior breast cancer history possess distinct, elevated risk profiles and clinical characteristics compared to the general population. Papers 0, 2, 4, 8, and 9 all directly or indirectly provide evidence confirming these elevated and unique risk profiles. No papers refute the claim.

Evidence for · 5

Liquid biopsy: a new window on the BRCA genes.

2026

Get citation

L, I., V, G., F, P., TD, B. R., M, S., C, M., G, C., U, M., ED, C., & A, R. (2026). Liquid biopsy: a new window on the BRCA genes.. doi.org. https://doi.org/10.1016/j.esmoop.2026.108349

See more details

More for · 4

Comprehensive Genomic Profiling Reveals the Mutational Spectrum and Clinical Significance of BRCA1/2 and Other Cancer-Susceptibility Genes in Breast Cancer Patients from Southern Tunisia.

2026

Get citation

N, A., R, A., W, B. K., D, B., S, G., A, F., H, K., A, K., J, D., GH, L., A, G., & R, M. (2026). Comprehensive Genomic Profiling Reveals the Mutational Spectrum and Clinical Significance of BRCA1/2 and Other Cancer-Susceptibility Genes in Breast Cancer Patients from Southern Tunisia.. doi.org. https://doi.org/10.3390/cancers18172810

Examining the connection between BRCA1/2 mutations and uterine cancer: a comprehensive review.

2026

Get citation

SM, S., SAS, N., F, N., M, K., H, G., MH, J., & A, R. (2026). Examining the connection between BRCA1/2 mutations and uterine cancer: a comprehensive review.. doi.org. https://doi.org/10.1097/ms9.0000000000005267

Clinicopathological characteristics and potential impact of previous treatment history in metachronous contralateral breast cancer: Insights from a real-world retrospective study.

2026

Get citation

R, S., K, Y., K, I., M, A., M, S., & G, K. (2026). Clinicopathological characteristics and potential impact of previous treatment history in metachronous contralateral breast cancer: Insights from a real-world retrospective study.. doi.org. https://doi.org/10.3892/ol.2026.15847

Evaluating the Performance of Mammogram-Based AI Risk Model in Predicting Subsequent Breast Cancer in Women with a Prior History of Breast Cancer.

2026

Get citation

SB, O., A, D., A, L., KA, R., S, M., M, V., & HP, L. (2026). Evaluating the Performance of Mammogram-Based AI Risk Model in Predicting Subsequent Breast Cancer in Women with a Prior History of Breast Cancer.. doi.org. https://doi.org/10.3390/jcm15176507

Receipt History

Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.

Check your own claim

Challenge the receipt

I have a source that contradicts this verdict I have a source that supports it No source: request a receipt review Requests are recorded for review. This does not start an automatic check or guarantee a response time.

See the evidence timeline

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work